Biobanks are emerging from the shadows of modern science as researchers and advocates launch a global campaign to show the public how profoundly these collections shape medicine, environmental protection, agriculture and scientific discovery. The new initiative, Global Biobank Awareness (GBA), aims to make the infrastructure behind biospecimen research more visible at a time when biobanks face growing pressure from uncertain funding, limited public understanding and competition for institutional support. Although biobanks underpin research across nearly every scientific discipline, the term remains unfamiliar to much of the public—and even to some professionals who rely on their services.
At their core, biobanks are organized repositories that collect, process, preserve and distribute biological materials together with information describing their origin, condition and associated data. Their holdings can include human blood, tissue, cells and DNA; animal specimens; plants and seeds; microorganisms; environmental samples; geological materials and historical artifacts. These collections are not simply warehouses of frozen material. They are complex scientific systems in which sample collection, consent, data management, quality control, temperature monitoring, ethical oversight and long-term stewardship must work together. When those processes are properly coordinated, a specimen collected years earlier can support new research questions and clinical applications that were impossible to anticipate at the time of donation.
Human and animal biospecimens are particularly important to precision medicine, an approach that seeks to match prevention and treatment to the biological characteristics of individuals or disease subgroups. Tumor tissue, blood plasma, DNA, RNA and other samples can help researchers identify molecular signatures, compare treatment responses and discover biomarkers that guide clinical decisions. However, the value of such material depends heavily on how it was collected and preserved. Delays before processing, inappropriate temperatures, repeated freeze-thaw cycles or incomplete clinical information can alter the biological properties of a specimen and compromise the reliability of downstream results. Biobanking therefore functions as a critical quality-control bridge between patients, research laboratories and healthcare systems.
“Biobanking is often overlooked or misunderstood for its complexity and its global impact,” said GBA co-chair Debra Leiolani Garcia. She noted that even researchers and institutions collaborating with biobanks may not immediately associate the term with the specialized expertise, infrastructure and stewardship required to maintain high-value collections. The initiative is designed to close that communication gap by presenting biobanking not as a narrow technical service, but as a global scientific discipline that connects donors, communities, researchers, clinicians, policymakers and future generations.
The technical demands of building a reliable biobank begin long before a sample enters a freezer. Collection protocols must define how specimens are obtained, labeled, transported and processed. Researchers must establish standardized operating procedures so that samples generated at different locations can be compared without introducing hidden sources of variation. Cryopreservation—the use of very low temperatures to slow or stop biological degradation—is central to many repositories, but it is not a universal solution. Different cells, tissues and organisms require different freezing rates, cryoprotective agents, storage temperatures and recovery procedures. Sophisticated facilities also need backup power, continuous environmental monitoring, alarm systems, validated equipment and contingency plans for disasters or equipment failure.
“Appropriate infrastructure, global regulatory and legislative approvals as well as a detailed understanding of standardized methodologies such as cryopreservation are essential to ensure that specimens yield the highest quality research data,” said GBA co-chair Cassandra Griffin. Her comments highlight a challenge that is often invisible outside the field: a specimen can appear intact while its molecular or cellular characteristics have already changed. Quality management systems are therefore essential for documenting every stage of a sample’s life, from consent and collection to access, analysis, redistribution and eventual disposal. These records help researchers assess whether a specimen is fit for a particular experiment and allow results to be interpreted in the context of the sample’s handling history.
The campaign also emphasizes that biobanks extend far beyond human medicine. The Svalbard Global Seed Vault has become one of the most recognizable examples of biological preservation, safeguarding crop diversity that may be needed to strengthen food systems in the face of pests, disease and climate change. Gene banks and seed banks preserve genetic resources that plant breeders can use to develop varieties adapted to drought, heat, salinity or emerging pathogens. Environmental biobanks can preserve samples of soil, water, air and microorganisms, enabling scientists to track ecological change and investigate biodiversity. Collections of animal tissues, microbes and geological materials can likewise provide evidence of evolution, ecosystem health and the history of environmental disturbance.
GBA launched in 2025 with an introductory video intended to demonstrate the breadth of biobanking across countries, disciplines and types of biological material. In 2026, the initiative plans to expand its public outreach through case studies and a dedicated Biobanking Awareness Week. Its organizers say the campaign differs from previous efforts because it is aimed not only at scientists and laboratory professionals, but also at patients, families, traditional custodians, educators, governments and the wider public. This broader approach reflects the reality that biobanks depend on communities. Donors and traditional custodians may provide the samples, knowledge or permissions that make collections possible, while patients and communities may ultimately benefit from discoveries made using those materials.
That relationship brings ethical and legal questions to the center of biobanking. Human collections require informed consent, privacy protections, responsible data governance and clear policies governing future research use. Indigenous and traditional knowledge may require additional forms of consultation, recognition and community authority. International collaborations must navigate differences in regulations governing genetic information, sample export, data sharing and commercialization. Public trust can be strengthened when institutions explain what is being collected, who can access it, how risks are managed and how research outcomes may be returned to the communities involved. Without that trust, even the most advanced repository may struggle to recruit donors or maintain a sustainable collection.
The organizers believe that greater visibility could influence the policy and funding decisions that determine whether biobanks survive and grow. Repositories require sustained investment rather than short-term support because their value often increases over time, as collections become richer and more research projects draw on them. Stable funding supports trained personnel, equipment maintenance, digital infrastructure, accreditation, quality assurance and long-term preservation. It also makes it possible to develop interoperable systems so that researchers can locate appropriate specimens across institutions while respecting access controls and privacy requirements. By showing how biobanks contribute to drug development, oncology, public health, conservation and climate resilience, GBA hopes to build a stronger case for these investments.
“Biobanking is a unique discipline of science, in which stakeholders such as donor patients or traditional custodians are essential advocates who underpin both our ability to collect samples and are likely to benefit from the research outcomes they generate,” Griffin said. The initiative’s co-chairs are calling on biobankers, scientific societies, universities, policymakers and allied communities to share examples of impact and participate in the campaign. Their objective is to make biobanking recognizable not as an invisible technical service, but as a public-facing foundation of discovery. If successful, the effort could help connect the frozen samples, careful protocols and global networks behind biobanking with the people whose health, food security and environment may depend on them.
Subject of Research: Cells
Article Title: Global Biobank Awareness: An Initiative to Showcase Impact and Increase Global Visibility of Biobanks
News Publication Date: 20-Jul-2026
Web References: Global Biobank Awareness, https://globalbiobankawareness.net; International Society for Biological and Environmental Repositories, https://www.isber.org; https://doi.org/10.1177/19475535261471389
References: Griffin CP, Garcia DL, Grossman GH. “Global Biobank Awareness: An Initiative to Showcase Impact and Increase Global Visibility of Biobanks.” Biopreservation and Biobanking. 2026;0(0). doi:10.1177/19475535261471389
Keywords: biobanks, biorepositories, biospecimens, biobanking awareness, cryopreservation, precision medicine, gene banks, seed banks, tissue banks, science policy
